(Q40290223)

19 September 2017

Metabolic biotinylation provides a unique platform for the purification and targeting of multiple AAV vector serotypes (English)

1 reference

19 September 2017

Gregory S Arnold

1

1 reference

19 September 2017

A Kate Sasser

series ordinal

2

1 reference

19 September 2017

Matthew D Stachler

series ordinal

3

1 reference

19 September 2017

Jeffrey S Bartlett

series ordinal

4

1 reference

19 September 2017

19 April 2006

1 reference

19 September 2017

1 reference

19 September 2017

14

1 reference

19 September 2017

97-106

1 reference

19 September 2017

1

1 reference

Adeno-associated virus type 5: transduction efficiency and cell-type specificity in the primate retina.

19 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.014

Improving rAAV production and purification: towards the definition of a scaleable process

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.014

Novel tools for production and purification of recombinant adenoassociated virus vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.014

Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.014

Incorporation of tumor-targeting peptides into recombinant adeno-associated virus capsids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.014

Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.014

Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.014

RGD inclusion in VP3 provides adeno-associated virus type 2 (AAV2)-based vectors with a heparan sulfate-independent cell entry mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.014

Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.014

The enzymatic biotinylation of proteins: a post-translational modification of exceptional specificity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.014

The avidin-biotin complex in bioanalytical applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.014

Phenotypic analysis of antigen-specific T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.014

Biotin tagging deletion analysis of domain limits involved in protein-macromolecular interactions. Mapping the tau binding domain of the DNA polymerase III alpha subunit.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.014

Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.014

Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.014

Identification of amino acid residues in the capsid proteins of adeno-associated virus type 2 that contribute to heparan sulfate proteoglycan binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.014

Serum-free production and column purification of adeno-associated virus type 5.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.014

Scalable purification of adeno-associated virus type 2, 4, or 5 using ion-exchange chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.014

Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.014

Recombinant AAV serotype 1 transduction efficiency and tropism in the murine brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.014

AAV vectors: is clinical success on the horizon?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.014

Cloning and characterization of Scavidin, a fusion protein for the targeted delivery of biotinylated molecules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.014

AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.014

Cell-type-specific characteristics modulate the transduction efficiency of adeno-associated virus type 2 and restrain infection of endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.014

Adeno-associated virus type 6 (AAV6) vectors mediate efficient transduction of airway epithelial cells in mouse lungs compared to that of AAV2 vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.014

Adeno-associated virus type 5 (AAV5) but not AAV2 binds to the apical surfaces of airway epithelia and facilitates gene transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.014

Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.014

Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.014

Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.014

Gene transfer into skeletal muscle using novel AAV serotypes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.014

Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.014

Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.014

Metabolic biotinylation of recombinant proteins in mammalian cells and in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.014

Characteristics of a human cell line transformed by DNA from human adenovirus type 5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.014

Role for highly regulated rep gene expression in adeno-associated virus vector production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.014

Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.014

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YMTHE.2006.02.014

1 reference

19 September 2017

1 reference